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Abstract
The objective of this study was to understand the impact of hazardous and harmful use of al-
cohol and/or other drugs on ARV adherence and disease progression among HIV patients.
A cross-sectional study design was used. A total of 1503 patients attending HIV clinics in
Cape Town, South Africa were screened for problematic substance use. A sub-sample of
607 patients (303 patients who screened positive for problematic substance use and 304
who did not) participated in this study. Hazardous or harmful alcohol use and problematic
drug use predicted missing and stopping ARVs which, in turn, was associated with a de-
crease in CD4 counts and more rapid HIV-disease progression and poorer health outcomes
in people living with HIV/AIDS (PLWHA). The findings of this study underscore the need for
an integrated approach to managing substance-use disorders in PLWHA.
Introduction
The human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)
have become a global pandemic and a major health challenge, especially in sub-Saharan Africa.
Substance use, like HIV, is another major health challenge facing these countries, particularly
South Africa. Since South Africa’s first democratic elections in 1994 and the country’s re-entry
into the global economy, there has also been an increase in drug trafficking. Although alcohol
continues to be the primary and most abused substance in South Africa, in recent years there
has been an increase in the use of heroin, cocaine and amphetamine-type stimulants [1].
In the Western Cape particularly, for the reporting period July-December 2013, 86% of all
admissions for substance abuse treatment were for methamphetamine (‘tik’), alcohol, cannabis
and heroin. Methamphetamine was reported in 33% as a primary substance of abuse, cannabis
was reported as common primary substance of abuse in 25% of admissions and Mandrax was
reported in 21% and heroin in 13% of admissions in the Western Cape [2].
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According to a national survey conducted in south Africa, overall 9.6% of South Africans
engaged in past-month binge drinking (4 or more drinks for females and 5 or more drinks for
males on one occasion) and 9% of the sample (men and women) was found to engage in haz-
ardous or harmful use of alcohol as defined by the AUDIT. This study concluded that there
was an increase in the prevalence of current, binge, and hazardous or harmful drinking from
2005 to 2008 in South Africa [3]. In South Africa one unit of drink contains 12 grammes of al-
cohol [4]. Levels of binge drinking (among drinkers) particularly high in South Africa com-
pared to other African countries [5].
There is overwhelming evidence in the literature regarding the relationship between sub-
stance use and HIV status [6]. In particular, studies have found high rates of substance use
among people who are HIV positive [7,8]. The types of substances referred to in such studies
range from alcohol to illicit drugs such as heroin, cocaine, marijuana, stimulants and other
drugs.
Most of this research has centred on substance use as a risk factor for contracting HIV.
However, recent research has focused on the impact of alcohol consumption in people who
have already contracted the virus. Hazardous or harmful use of alcohol in people living with
HIV/AIDS (PLWHA) was found to be associated with poor adherence to ARVs, re-infection,
decreased viral suppression, increased viral replication and earlier onset of death [9,10].The
combined hazardous use of alcohol and drugs was also associated with the lowest odds of ARV
use adherence and viral suppression [11]. In a similar vein, stimulant use among PLWHA was
found to predict faster HIV disease progression, decrease in CD4 counts and AIDS related
mortality [12].
Taken together, these studies provide strong evidence for the role of substance abuse in ad-
vancing disease progression by diminishing adherence to the ARV regimen. Furthermore, the
impact on ARV adherence by alcohol and drug abuse is both singular and collective, with the
combined effect leading to significantly poorer health outcomes.
However, in South Africa, few studies have focused on the relationship between alcohol
abuse and poor ARV adherence [13,14]. This is the first study that investigated both alcohol
and drug abuse and its relationship to ARV adherence in South Africa. The objectives of this
study were to determine the predictors of hazardous or harmful use of alcohol and problematic
drug use, and the impact of these on ARV adherence and CD4 counts.
Materials and Methods
A cross-sectional study design was used. The power calculation for this study indicated that a
sample size of 1 503 participants was needed. A total of 1503 patients attending 15 HIV clinics
in Cape Town, South Africa were screened for alcohol and drug use, using the Alcohol Use Dis-
orders Identification Test (AUDIT) and/or on the Drug Use Disorders Identification Test
(DUDIT).For further sub analyses a significance level of 0.025 and power of 90% were speci-
fied. This yielded an optimal sample size of 216 substance abusers. To boost the sub-analyses of
data, we included 303 substance abusers (i.e. patients who scored above the cut-off score of 8
for both men and women on the AUDIT and a cut-off score of 6 or more for men, and a cut-
off score of 2 points for woman was used for the DUDIT) and a comparison group of 304 non-
substance abusers (i.e. patients who scored below the cut-off score on the AUDIT and DUDIT)
at the eight clinics. The selection of these 607 participants from the 1503 to participate further
comprised the first 38 patients selected randomly at each of the eight clinics who were sub-
stance abusers and the first 38 patients who were not substance abusers. The sample was drawn
from clinics deemed by the Department of Health to be representative of all state funded HIV
clinics in the metropole.
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Patients attending these HIV clinics were informed of the study by their attending clinician
(nurse, doctor, HIV counsellor). If patients showed an interest in participating in the study,
they were referred to the trained fieldworkers for this study.
All participants completed written informed consent forms prior to participation in the
study, and these forms were stored as official record of the informed consent. The consent pro-
cedure was approved by Human Research Ethics Committee of the Health Science Faculty of
the Stellenbosch University, which also approved the entire study, ref no: N08/10/294. The
committee thus considered the patient information procedure ethically adequate for this study.
Questionnaires were administered in the participant’s language of choice (Afrikaans, Xhosa
and English) and all translations were done using the double blind technique. Participants who
were found on the AUDIT and/or DUDIT to be possibly alcohol or drug dependent were re-
ferred for treatment.
Instruments
Socio-demographic variables and health characteristics. A brief questionnaire was used
to collect relevant demographic information (age, race, gender, etc.) from the participant and
clinical records were used to obtain clinical information (date of diagnosis, date of commence-
ment of ARVs, date of diagnosis of tuberculosis (TB) and opportunistic infections, etc.). As
used in this study, race (the categories of “white", "black", and "Coloured”) refers to demo-
graphic markers and does not denote any inherent characteristics. Their continued use in
South Africa is important for monitoring improvements in health and socio-economic dispari-
ties, identifying vulnerable sections of the population, and planning effective prevention and
intervention programmes.
The Alcohol Use Disorders Identification Test (AUDIT). The AUDIT was developed by
the World Health Organisation and is used to screen people with hazardous and harmful pat-
terns of alcohol use and alcohol dependence. The AUDIT is scored as follows: 0–7 indicates ab-
stinence or low-risk drinking; 8–15 is indicative of hazardous drinking patterns; 16–19
indicates harmful levels of drinking and 20–40 indicates possible dependence [15]. The Cron-
bach alpha for the AUDIT was 0.81 for this sample.
The Drug Use Disorders Identification Test (DUDIT). The DUDIT is a screening in-
strument used to screen people with problematic drug use. A score of 6 or more indicates prob-
lematic drug use in men and a score of 2 or more indicates the same in women. For both
genders, a score 25 or more indicates a high probability of dependence on one or more drugs
[16].The Cronbach alpha for the DUDIT was 0.76 for this sample.
ARV Adherence Assessment. Two instruments were used to assess ARV adherence,
the Morisky Scale and the ARV Adherence Questionnaire. The Morisky Scale is a self-report
measure shown to have sound concurrent and predictive validity [17]. The ARV Adherence
Questionnaire was used as adapted in a previous South African study [18].The questionnaire
assesses various reasons for missing ARV doses and stopping ARVs. ARV adherence was mea-
sured in terms of missing ARVs and stopping ARVs. Missing ARVs comprised not taking
ARVs for the following reasons: they did not want others to see they were taking medication,
they were away from home, they just forgot, because they were busy with other things. Stop-
ping ARVs was defined as participants stopping their medication for any of a number of rea-
sons, e.g., because they felt better, felt sick or depressed, felt overwhelmed by the number of
pills, worried about getting side effects from medication, actually getting side effects from med-
ication and because they ran out of pills. The Cronbach alpha for the Morisky Scale was 0.62
and for the ARV Adherence Questionnaire it was 0.73 for this sample.
The Impact of Alcohol and Drug Use on ARV Adherence
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Data Analysis
All data was analysed using SPSS, version18. A 95% confidence interval and a 5% level of sig-
nificance were used to interpret statistical significance. All statistical tests were two-tailed. De-
scriptive analyses (means, standard deviations and frequencies) were used to describe
demographic data and clinical characteristics.
Univariate tests of association for categorical variables (chi-square tests) were used to exam-
ine associations between problematic drug use and gender, ARV adherence (stopping, missing
a dose, being careless and forgetting to take ARVs). The t-test was used to test for group differ-
ences on hazardous or harmful use of alcohol and across gender and ARV adherence. Pearson
correlations were employed to assess the relationship between hazardous or harmful use of al-
cohol and CD4 count. Multivariate linear relationships were explored using regression
analysis.
Following the regression analysis, a path analysis model was developed to examine 1) the
determinants of hazardous or harmful alcohol and/or problematic drug use, and 2) the impact
of these on ARV adherence and CD4 counts. Variables for the model were selected on the basis
of the bivariate and regression analyses.
Results
Descriptive and Bivariate Analysis
Demographic characteristics. The sample consisted almost entirely of Black (89%)
and Coloured (10%) participants reflecting the demographics of the population of PLWHA
attending the public clinics were data collection occurred. The mean age of participants was
35.9 years. Most participants were female (67.5%), single (64.1%), unemployed (66.7%), and
had some high-school education (62.3%). The monthly income for most of the participants
(62.4%) was less than R1 000 (US$120) and 35% earned between R1 000 and R5 000 per
month (US$120 and US$602) (Table 1).
Health status. The average time between diagnosis of HIV and data collection was
3.8 years. The current mean CD4 count was 305.5 and the CD4 nadir (lowest CD4 count in the
previous 12 months) was 264.8. The majority of the participants, 539 (88.8%) were on ARVs.
Hazardous or harmful use of alcohol and problematic drug use. Just under half of all
participants (46%) scored at or above the clinically significant cut-off score of8 on the
AUDIT, indicating the likelihood of hazardous or harmful drinking, and 15% scored above the
respective cut-off points on the DUDIT, indicating problematic drug use.
Gender Differences. There were significant gender differences in the hazardous or harm-
ful use of alcohol, with males being significantly more likely than females to engage in hazard-
ous or harmful use of alcohol (t = 4.988, p = 0.00). Similarly, there were significant gender
differences in problematic drug use (x2 = 43.185, p = 0.00), and males were three times more
likely to be problematic drug users than females. Moreover, there was a significant association
between gender and missing ARV doses (x2 = 6.326, p = 0.01). More males (48.2%) than fe-
males (36.8%) reported missing a dose of ARVs. There was a significant association between
gender and CD4 counts (t = -2.825, p< 0.00) with females having significantly higher CD4
counts than males.
ARV adherence. There was a significant association between hazardous or harmful use of
alcohol and stopping ARVs (t = -5.364, p = 0.00), missing ARV doses (t = -7.737, p = 0.00), for-
getting to take ARVs (t = 6.264, p = 0.00), and being careless about taking ARVs (t = 7.773,
p = 0.00). Participants reporting hazardous or harmful use of alcohol were significantly more
The Impact of Alcohol and Drug Use on ARV Adherence
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Table 1. Demographic characteristics of the sample.
MEAN AGE (35.91) SD = 8.0
GENDER n %
Male 197 32.5
Female 410 67.5
RACE
Black 541 89.1
Coloured 62 10.2
Other 4 0.7
CURRENT MARITAL STATUS
Single 389 64.1
Widowed 25 4.1
Separated 19 3.1
Divorced 13 2.1
Married or living with a signiﬁcant other 161 27.5
CURRENT LIVING SITUATION
Live alone 81 13.3
Live with other adults, no children 122 20.1
Live with other adults and children 285 47.0
Live with children 119 19.6
HIGHEST LEVEL OF EDUCATION COMPLETED
No formal education 49 8.1
Completed primary school 102 16.8
Attended high school but did not complete matric (Grade 12) 378 62.3
Completed matric (Grade 12) 69 11.4
Attended university, college or technikon but did not graduate 4 0.7
Graduated from university, college or technikon 5 0.8
CURRENT MARITAL STATUS
Single 389 64.1
Widowed 25 4.1
Separated 19 3.1
Divorced 13 2.1
Married or living with a signiﬁcant other 161 27.5
CURRENT LIVING SITUATION
Live alone 81 13.3
Live with other adults, no children 122 20.1
Live with other adults and children 285 47.0
Live with children 119 19.6
CURRENT WORK SITUATION
Employed full time 99 16.3
Employed part time 85 14.0
Student 7 1.2
Unemployed 405 66.7
Disabled 9 1.5
Homemaker 1 0.2
Retired 1 0.2
doi:10.1371/journal.pone.0125088.t001
The Impact of Alcohol and Drug Use on ARV Adherence
PLOS ONE | DOI:10.1371/journal.pone.0125088 May 1, 2015 5 / 12
likely to either stop, miss, forget or be careless about taking their ARVs than their counterparts
without alcohol problems.
There was a similarly significant association between problematic drug use and stopping
ARVs (x2 = 5.915, p = 0.05), missing ARV doses (x2 = 31.794, p = 0.00), forgetting to take
ARVs (x2 = 13.987, p = 0.00), and being careless about taking ARVS (x2 = 19.852, p< 0.05).
Participants with problematic drug use were much more likely to stop their ARVs and were
three times more likely to miss taking their ARVs than participants without drug problems.
Problematic drug users were also almost twice as likely to forget to take their ARVs or be care-
less about taking them than their counterparts without these drug problems.
CD4 Counts. There was a significant negative correlation between AUDIT total scores
and CD4 counts: as the AUDIT total scores increased, CD4 counts decreased (r = -0.106,
p = 0.01). There was no significant correlation between DUDIT scores and CD4 counts
(t = 0.935, p = 0.35).
Logistic Regression Analysis
As a precursor to the path analysis model logistic regression analysis was conducted to examine
the impact of various demographic and substance abuse behaviours on ARV adherence. The
results of this analysis are presented in Table 2 and Table 3. For the purposes of the logistic
Table 2. Determinants of Missing ARVs—Logistic Regression Analysis.
Missed medication a B Sig. Exp(B) 95% Conﬁdence Interval for Exp(B)
Lower Bound Upper Bound
Missed medication Intercept -1.343 .006
AGE -.010 .417 .990 .965 1.015
AUDIT .055 .000 1.057 1.037 1.076
DUDIT .558 .000 1.747 1.298 2.350
Male .062 .779 1.064 .689 1.645
Female 0 . . . .
Employed .270 .198 1.310 .868 1.975
Unemployed 0 . . . .
a The reference category is: Never missed medication.
doi:10.1371/journal.pone.0125088.t002
Table 3. Determinants of Stopping ARVs—Logistic Regression Analysis.
Stopped Medication a B Sig. Exp(B) 95% Conﬁdence Interval for Exp(B)
Lower Bound Upper Bound
Stopped medication Intercept -1.637 .006
AGE -.012 .433 .988 .958 1.019
AUDIT .052 .000 1.054 1.031 1.076
DUDIT .100 .536 1.105 .805 1.518
Male -.052 .849 .950 .559 1.613
Female 0 . . . .
Employed -.290 .287 .748 .439 1.276
Unemployed 0 . . . .
a The reference category is: Never stopped medication.
doi:10.1371/journal.pone.0125088.t003
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regression and path analysis, the employment variable was recoded into a binary variable (Em-
ployed/Unemployed), while gender and age were treated as originally measured. The remain-
ing demographic variables were not entered into the logistic regression and path analysis
modelling as a result of lack of bivariate statistical significance between each of these variables
and AUDIT and DUDIT.
The logistic regression analysis revealed that AUDIT total scores was the only significant de-
terminant of stopping ARVs, and both AUDIT and DUDIT total scores were significant deter-
minants of missing ARVs. The lack of statistical significance for the demographic variables was
not surprising as it was hypothesized, as will be seen later in the path analysis model, that these
variables would be directly significant in determining substance abuse behaviours, and that
these substance abuse behaviours would in turn be direct determinants of ARV adherence.
Path Analysis Modelling
To test for the simultaneous impact of the various demographic and substance abuse variables
on ARV adherence and CD4 counts, a path analysis model was specified and tested (Fig 1). As
the model featured ARV adherence data, participants who were not on ARVs were excluded
from the analysis. The results of the path analysis modelling revealed that there were no residu-
al errors and no data problems with the measurement model, thereby permitting the use of
model indices and the interpretation of model results. The output indicated that the structural
model provided a good fit to the data, as indicated by the following indices:
Fig 1. Modelling determinants of ARV adherence and health status.
doi:10.1371/journal.pone.0125088.g001
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• CFI = 0.99 (a CFI of 0.90 and above is regarded as a well-fitting model)
• Root Mean Square Error of Approximation (RMSEA) = 0.021 (a RMSEA value of 0.03 and
0.05 is regarded as evidence of a good fitting model)
• χ2 = 13.3 with df = 11 and χ2/df ratio of 1.218 (a χ2/df ratio of 1 to 4 is considered as evidence
of a good model).
Furthermore, the Lagrange Multiplier Tests outputs confirmed the validity of the good fit
indices and indicated that no further modifications were necessary to the model.
Looking more closely at the tested model, a number of significant direct predictive pathways
were identified:
1. Gender was found to be significant in predicting the harmful and hazardous use of alcohol
(ß = - 0.21, p = 0.00) and drugs (ß = - 0.24, p = 0.00), with males registering significantly
higher levels of problematic substance use than females.
2. Gender (ß = - 0.24, p = 0.00) and age (ß = 0.11, p = 0.01) were found to be significant in di-
rectly predicting CD4 counts: being male and of younger ages was predictive of significantly
lower CD4 counts.
3. Unemployment was found to be a direct determinant of alcohol use (ß = 0.13, p = 0.00) and
drugs (ß = 0.08, p = 0.05), with the unemployed being significantly more likely to engage in
the harmful and hazardous use of alcohol and drugs.
4. Harmful and hazardous use of alcohol (ß = 0.16, p = 0.00) was a direct determinant of prob-
lematic drug use: those who indicated harmful and hazardous use of alcohol were more like-
ly to engage in problematic drug use.
5. Harmful and hazardous use of alcohol was a direct determinant of missing ARVs (ß = 0.27,
p = 0.00) and stopping ARVs (ß = 0.15, p = 0.00), while problematic drug use was a signifi-
cant determinant of missing ARVS (ß = 0.17, p = 0.00) but not stopping ARVs (ß = -0.03,
p = 0.49).
6. Missed ARVs was found to predict stopping ARVs (ß = 0.34, p = 0.00 participants who
missed taking their ARVs were more likely to stop taking their ARVs.
7. Stopping ARVs (ß = -0.09, p = 0.04) significantly predicted CD4 counts: those who stopped
taking their ARVs had significantly lower CD4 counts.
Discussion
The results indicate that harmful and hazardous use of alcohol and problematic drug use are
statistically significant and important determinants of ARV adherence, and consequently, of
health outcomes as measured by CD4 counts. In terms of determining patterns of substance
abuse, gender and unemployment were found to be significant in terms of determining sub-
stance abuse, with males and the unemployed being more likely to engage in such behaviours.
In terms of ARV adherence, substance abuse has nuanced effects.The harmful and hazard-
ous use of alcohol was found to have direct significant impacts on all forms of ARV adherence
(missing and stopping ARVS), while problematic drug use was found to only impact on miss-
ing and not stopping ARVS. However, those who missed their ARVS were more likely to also
stop them, indicating an indirect effect for problematic drug use. This is consistent with find-
ings from a study that reported that hazardous drinkers, heavy drinkers and binge drinkers
were more likely to miss a dose of medication or to take medication off-schedule [7].Similarly,
The Impact of Alcohol and Drug Use on ARV Adherence
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another reported that hazardous or harmful drinkers of alcohol were nine times more likely to
not adhere to ARVs than their non-drinking counterparts [19].This is consistent with a study
that reported alcohol users were over five times more likely to be non-adherent compared
to participants who did not use alcohol [20]. In a meta-analysis of the association between
alcohol use and ARV adherence alcohol users were 50%-60% as likely to be adherent to ARVs
compared to those who abstained from alcohol or drank relatively less [10].Several factors
moderated the association between alcohol and ARV adherence in this study, such as a higher
proportion of men being non-adherent, which is consistent with the findings of this study.
The prevalence of hazardous and harmful use of alcohol in this study is much higher than
was previously documented in studies conducted in sub-Saharan Africa where hazardous or
harmful use of alcohol was reported to range between 2.6% to 24.3% in PLWHA [21,22,23,24].
Similarly, studies in South Africa have reported lower rates of alcohol abuse/dependence in
PLWHA than in the current study, ranging from 7% to 12.9% but this could be partly due to
differing measuring approaches [25,26,27].
Furthermore, hazardous or harmful alcohol use was a direct predictor of problematic drug
use, which in turn, predicted poorer adherence and lower CD4 counts. These findings are con-
sistent with the findings of a study in which problem drinking was reported to be associated
with illicit drug use and binge drinking and non-adherence to HAART [28].Similarly, other
studies have documented that active drug users underutilized HAART compared to former
and non-drug users and had sub-optimal virologic and immunologic responses to antiretrovi-
ral therapy [29].The rate of problematic drug use (15%) is comparable to a study that reported
that 9% of PLWHAmet the criteria for drug dependence in the previous 12 months and 10%
abusing drugs [30].This rate is considerably lower than international studies where current
drug use in PLWHA is in the order of 46%-64% [31,32].
Gender and unemployment were found to be significant determinants of substance use with
more males reporting hazardous or harmful use of alcohol and/or drugs. Being male and of a
younger age were also found to be a significant determinant of lower CD4 counts. These find-
ings are further substantiated by studies conducted in South Africa examining the role of gen-
der, age, unemployment and other socio-demographic factors in determining problematic
substance use and ARV poor adherence [25,26,33].
The study found that harmful and hazardous use of alcohol and/or drugs has an impact on
ARV adherence. ARV adherence impacts on diminished health status, i.e., lower CD4 counts,
only in the most extreme version where ARVs were stopped, while the less extreme version of
non-adherence, i.e., missing ARVs did not have a similar significant effect on CD4 counts.
Taken together, this suggests that patients who stop ARVs are at greatest risk for a higher viral
load, while those who miss their ARVs are at less risk, though this risk could escalate as missing
ARVs could easily also lead to actually stopping them.
There are a number of limitations that deserve mentioning. Firstly, the sample was drawn
from the Cape Metropole area and may not be representative of the HIV-treatment seeking
population across South Africa with regards to patterns of substance use and ARV adherence.
Secondly, the reporting of alcohol and drug use was measured by self-reports and not con-
firmed by laboratory testing for alcohol and drug abuse. However, it should be noted that a
pilot study among PLWHA comparing self-report alcohol and drug use with urine and hair
tests reinforced the value of self-report data on alcohol and drugs [34].Thirdly, the reporting of
ARVs was also measured by self-reports and not confirmed by objective biological markers.
Study findings have revealed that patients’ self-reporting on ARV adherence tend to overesti-
mate adherence when compared to objective measures, such as electronic monitoring [35].
Therefore, a more standardised and objective method of assessing ARVs should be considered
that will provide a more accurate measurement of ARV adherence in future.
The Impact of Alcohol and Drug Use on ARV Adherence
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Fourthly, the multivariate models are limited in that they only account for the impact of var-
iables selected for inclusion in the analysis. This implies that further models employing other
determinant variables—demographic or behavioural—might lead to different results. For in-
stance, the impact of substance abuse on ARV adherence may be mediated or moderated by
the presence of co-occurring psychiatric conditions such as depression, anxiety and post trau-
matic stress disorder. These factors may also play a role in directly impacting the clinical status
of patients receiving ARVs. However, the purpose of the research was not to examine an ex-
haustive list of likely determinants, but rather to clarify the relative strength of determination
of the identified variables. Despite these limitations, this study makes an important contribu-
tion in identifying multiple predictors of ARV adherence and CD4 count and the association
with health outcomes of PLWHA. However, of importance and to our knowledge, this is the
first large systematic investigation of problematic alcohol and drug use in a representative sam-
ple of persons receiving treatment from HIV clinics in South Africa. Therefore, it can form the
basis for replication studies in other parts of the country, including more longitudinal studies
of PLWHA.
Conclusion
The findings of this study underscore the need for an integrated approach to managing sub-
stance-use disorders in PLWHA. Screening for substance use in PLWHA should be standard
practice and conducted routinely at primary health-care centres. The integration of substance
use and HIV services should be considered to ensure that patients are seen at a single facility.
Cross-training staff at HIV and substance abuse centres should be considered. Cross-training
should focus on the link between substance abuse, mental health problems and HIV/AIDS,
and on screening. Primary health- care workers should also be cross-trained to identify these
disorders and refer appropriately where necessary [36].
Screening instruments are cost effective and can be easily administered by any health pro-
fessional required they are given the proper training. For example, when using the AUDIT as a
screening instrument; patients who are screened as low-risk drinkers should be given informa-
tion about the risks of drinking. Medium-risk drinkers could be given simple advice, brief
counselling and their drinking monitored at follow-up visits and patients who are high-risk
drinkers could be referred to a specialist for further diagnosis and treatment [15]. In addition,
treatment providers should inquire about drug use and poly-drug use before prescribing
ARVs [37].
It could also help considering using some form of Daily Observed Treatment System
(DOTS) to improve adherence, that could be rolled out to patients at primary health-care facili-
ties and includes family and friends [37]. Furthermore, PLWHA should be referred for active
case management to limit re-infection or non-adherence to medication.
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